CRO company 62704
VYGON (IRELAND) LIMITED
Vygon (Ireland) Limited is company 62704 on the CRO register, with its registered office in Dublin. It is named as a supplier on 9 published public contract awards, from 2 public bodies, most often Health Service Executive (HSE). The latest is dated 10 November 2023.
- Company number
- 62704
- Status
- Normal
- Type
- LTD - Private Company Limited by Shares
- Registered
- 1978-05-16
- Registered office
- UNIT F10, BALDONNELL BUSINESS PARK, CLONLARA ROAD DUBLIN 22, DUBLIN 22
- Latest accounts made up to
- 2025-12-31
- Last annual return
- 2026-05-06
- Next annual return date
- 2027-08-22
- Current type since
- 2016-12-01
- 9
- Awards
- None
- Sole-supplier value
- 9
- Shared awards
- 0
- Declared by politicians
Every award names several suppliers
€438,000,000 in total across all named suppliers; each supplier's share is not published
Directors, secretaries and shareholders are not in CRO's open data. CRO sells officer information through CORE; it is not shown here rather than guessed.
Years
Tab moves through the graph entities, then on to the evidence panel. Press Enter or Space to inspect an entity, and Escape to clear the current selection.
Records by year · select a year to filter
Awards by year
sole supplier shared
Top buyers
Awards · sole-supplier value
Latest awards
All 9 contracts- Multi-Supplier Framework for the supply of Veterinary Products and Consumables to University College Dublin School of Veterinary MedicineEducation Procurement Service (EPS)€10,000,000Shared
- Tender for the establishment of a National Framework Agreement for the provision of Neurology Products and ConsumablesHealth Service Executive (HSE)€40,000,000Shared
- Tender for the establishment of a National Framework Agreement for the provision of Surgical Drapes and PacksHealth Service Executive (HSE)€40,000,000Shared
- Tender for the establishment of a National Framework Agreement for the provision of Sutures and ClosuresHealth Service Executive (HSE)€28,000,000Shared
- Tender for the establishment of a National Framework Agreement for the provision of Interventional CardiologyProducts and Consumables. (II)Health Service Executive (HSE)€60,000,000Shared